Resistance to antibiotics is increasing worldwide. This also applies to drugs that are central to the treatment of tuberculosis (TB), such as bedaquiline. An international panel of experts from 32 countries has therefore presented specific antimicrobial stewardship standards for TB care for the first time. The recommendations, published in the International Journal of Tuberculosis and Lung Disease, aim to anchor tuberculosis more firmly in antimicrobial stewardship structures, optimize resistance monitoring and diagnostics, and improve the quality of treatment in the long term.